Heparin-Induced Thrombocytopenia

Weismann RE , Tobin RW Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219-227, 1958.

Roberts B. , Rosato FE , Fosato EE Heparin—A cause of arterial emboli? Surgery 55: 803-808, 1964.

Rhodes GR , Dixon RH , Silver D. Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations . Surg Gynecol Obstet 136:409-416, 1973.

Fratantoni JC , Pollet R. , Gralnick HR Heparin-induced thrombocytopenia: Confirmation of diagnosis with in vitro methods. Blood 45:395-401, 1975.

Babcock RB , Dumper CW , Scharfman WB Heparin-induced immune thrombocytopenia. N Engl J Med 295:237-241, 1976.

Rhodes GR , Dixon RH , Silver D. Heparin-induced thrombocytopenia: Eight cases with thombotic-hemmorrhagic complications. Ann Surg 186:752-758, 1977.

Green D. , Harris K. , Reynolds N. , Roberts M. , Patterson R. Heparin immune thrombocytopenia: Evidence for a heparin-platelet complex as the antigenic determinant. J Lab Clin Med 91:167-175, 1978.

Wahl TO , Lipschitz DA , Stechschulte DJ Thrombocytopenia associated with antiheparin antibody. JAMA 240:2560-2562, 1978.

Trowbridge AA , Caraveo J. , Green JB , Amaral B. , Stone MJ Heparin-related immune thrombocytopenia. Am J Med 65:277-283, 1978.

Nelson JC , Lerner RG , Goldstein R. , Cagin NA Heparin-induced thrombocytopenia. Arch Intern Med 138:548-552, 1978.

Hussey VC , Bernhard VM , McLean MR , Fobian JE Heparin-induced platelet aggregation: In vitro confirmation of thrombotic complications associated with heparin therapy. Ann Clin Lab 9:487-493, 1979.

Cimo PL , Moake JL , Weinger RS , Ben-Menachem Y. , Khalil KG Heparin-induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses. Am J Hematol 6:125-133, 1979.

Towne JB , Bernhard VM , Hussey C. , Garancis JC White clot syndrome. Peripheral vascular complications of heparin therapy . Arch Surg 114:372-377, 1979.

Hussey CV , Bernhard VM , McLean MR , Fobian JE Heparin-induced platelet aggregation: In vitro confirmation of thrombotic complications associated with heparin therapy. Ann Clin Lab Sci 9:487-493, 1979.

Cines DB , Kaywin P. , Bina M. , Tomaski A. , Schreiber AD Heparin-associated thrombocytopenia. N Engl J Med 303:788-795, 1980.

Kapsch D. , Silver D. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 116:1423-1427, 1981 .

Chong BH , Grace CS , Rozenberg MC Heparin-induced thrombocytopenia: Effect of heparin platelet antibody on platelets . Br J Haematol 49:531-540, 1981.

Chong BH , Pitney WR , Castaldi PA Heparin-induced thrombocytopenia: Association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 2:1246-1248, 1982.

Stead RB , Schafer AI , Rosenberg RD , Handin RI , Josa M. , Khuri SF Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism . Am J Med 77: 185-188, 1984.

Silver D. , Kapsch DN , Tsoi EK Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg 198:301-305, 1983.

Guay DR , Richard A. Heparin-induced thrombocytopenia—Association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin. Drug Intell Clin Pharm 18:398-401, 1984.

Sandler RM , Seifer DB , Morgan K. , Pockros PJ , Wypych J. , Weiss LM , Schiffman S. Heparin-induced thrombocytopenia and thrombosis: Detection and specificity of a platelet-aggregating IgG. Am J Clin Pathol 83:760-764, 1985.

Lynch DM , Howe SE Heparin-associated thrombocytopenia: Antibody binding specificity to platelet antigens. Blood 66:1176-1181, 1985 .

Wolf H. , Glassl H. , Nowack H. , Wick G. Identification of binding site for heparin and other polysulfated glycosaminoglycans on human thrombocytes. Int Arch Allergy Appl Immunol 80:231-238, 1986.

Pfueller SL , David R. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia . Br J Haematol 64: 149-159, 1986.

Chong BH , Castaldi PA Heparin-induced thrombocytopenia: Further studies of the effects of heparin-dependent antibodies on platelets. Br J Haematol 64:347-354, 1986.

Cines DB , Tomaski A. , Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia . N Engl J Med 316:581-589, 1987.

Kelton JG , Sheridan D. , Santos A. , Smith J. , Steeves K. , Smith C. , Brown C. , Murphy WG Heparin-induced thrombocytopenia: Laboratory studies. Blood 72:925-930, 1988.

Chong BH , Fawaz I. , Chesterman CN , Berndt MC Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235-240, 1989.

Hirsh J. Drug therapy: Heparin. N Engl J Med 324:1565-1574, 1991.

Casu B. Methods of structural analysis. In Lane DA , Lindahl U , eds. Heparin, Chemical and Biological Properties, Clinical Applications. Boca Raton: CRC Press, 1989, pp 25-49.

Fidlar E. , Jaques LB The effect of commercial heparin on the platelet count. J Lab Clin Med 33:1410-1423, 1948.

Copley AL , Robb TP The effect of heparin on the platelet count in dogs and mice. Am J Physiol 133:248, 1941.

Gollub S. , Ulin AW Heparin-induced thrombocytopenia in man. J Lab Clin Med 59: 430-435, 1962.

Davey MG , Lander H. Effect of injected heparin on platelet levels in man. J Clin Pathol 21:55-59, 1968.

Shojania AM , Turnbull G. Effect of heparin on platelet count and platelet aggregation. Am J Hematol 26:255-262, 1987.

Mikhailidis DP , Fonseca VA , Barradas MA , Jeremy JY , Dandona P. Platelet activation following intravenous injection of a conventional heparin: Absence of effect with a low molecular weight heparinoid (Org 10172). Br J Clin Pharmacol 24:415-424, 1987.

Bjoraker DG , Ketcham TR Hemodynamic and platelet response to the bolus intravenous administration of porcine heparin. Thromb Haemost 49:1-4, 1983.

Davies GC , Sobel M. , Salzman EW Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation 61:808-814, 1980.

Heinrich D. , Gorg T. , Schulz M. Effects of unfractionated and fractionated heparin on platelet function . Haemostasis 18(Suppl 3):48-54, 1988.

Sobel M. , Conroy R. , Marques D. On the mechanism of heparin-mediated platelet aggregation. Blood 74:412a, 1989.

Schwartz KA , Royer G. , Kaufman DB , Penner JA Complications of heparin administration in normal individuals. Am J Hematol 19:355-363, 1985.

Sobel M. , Adelman B. Characterization of platelet binding of heparins and other glycosaminoglycans . Thromb Res 50:815-826, 1988.

Horne MK III , Chao ES Heparin binding to resting and activated platelets . Blood 74: 238-243, 1989.

Salzman EW , Rosenberg RD , Smith MH , Lindon JN Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64-73, 1980.

Sobel M. , McNeill PM , Carlson P. , Kermode JC , Adelman B. , Conroy R. , Marques D. Heparin inhibition of von Willebrand factor in vitro and in vivo. J Clin Invest 87: 1787-1793, 1991 .

Heiden D. , Mielke CH Jr , Rodvien R. Impairment by heparin of primary haemostasis and platelet [14C]5-hydroxytryptamine release. Br J Haematol 36:427-436, 1977.

Sobel M. , Adelman B. , Szentpetery S. , Hoffman M. , Jenvey W Surgical management of heparin-associated thrombocytopenia: Strategies in the treatment of venous and arterial thromboembolism. J Vasc Surg 8:395-401, 1988.

AbuRahma AF , Boland JP , Witsberger T. Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 162:175-179, 1991.

Powers PJ , Cuthbert D. , Hirsh J. Thrombocytopenia found uncommonly during heparin therapy. JAMA 241:2396-2397, 1979.

Johnson RA , Lazarus KH , Henry DH Heparin-induced thrombocytopenia: A prospective study Am J Hematol 17:349-353, 1984.

Gruel Y. , Lang M. , Darnige L. , Pacouret G. , Dreyfus X. , Leroy J. , Charbonnier B. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis. Lancet 336:1077-1078, 1990 .

Walls JT , Curtis JJ , Silver D. , Boley TM , Schmaltz RA , Nawarawong W Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition. Ann Thorac Surg 53:787-791, 1992.

Laster JL , Nichols WK , Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med 149: 2285-2287, 1989.

Garcia S. , Cervero A. , Sanchez M. , Colomina P. Heparin-associated thrombocytopenia in a patient with polycythemia vera: The importance of a marked drop in platelet count. Acta Haematol 85:169-170, 1991.

McCrae KR , Shattil SJ , Cines DB Platelet activation induces increased Fc gamma receptor expression. J Immunol 144:3920-3927, 1990.

Jenvey WI , Sobel M. Anaphylactoid reactions to heparin. Circulation 78-II:615, 1988.

Ansell JE , Clark WP , Compton CC Fatal reactions associated with intravenous heparin. Drug Intell Clin Pharm 20:74-75, 1986.

Fowlie J. , Stanton PD , Anderson JR Heparin-associated skin necrosis. Postgrad Med J 66: 573-575, 1990.

Stricker H. , Lammle B. , Furlan M. , Sulzer I. Heparin-dependent in vitro aggregation of normal platelets by plasma of a patient with heparin-induced skin necrosis: Specific diagnostic test for a rare side effect. Am J Med 85:721-724, 1988.

Humphries JE , Kaplan DM , Bolton WK Heparin skin necrosis: Delayed occurrence in a patient on hemodialysis. Am J Kidney Dis 17:233-236, 1991.

Roland JG , Massade E. , Serrano M. , Touzain F. , Franco A. Thrombocytopenia under low molecular weight heparin with fraxiparin dependent anti-platelet antibodies. Therapie 46:498, 1991.

Follea G. , Hamandjian I. , Trzeciak M. , Nedey C. , Streichenberger R. , Dechavanne M. Pentosane polysulphate associated thrombocytopenia. Thromb Res 42:413-418, 1986.

Spadone D. , Clark F. , James E. , Laster J. , Hoch J. , Silver D. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 15:306-312, 1992.

King DJ , Kelton JG Heparin-associated thrombocytopenia. Ann Intern Med 100: 535-540, 1984.

Laster J. , Cikrit D. , Walker N. , Silver D. The heparin-induced thrombocytopenia syndrome: An update. Surgery 102:763-770, 1987.

Hrushesky WJ Subcutaneous heparin-induced thrombocytopenia . Arch Intern Med 138: 1489-1491, 1978 .

Bailey RT Jr , Ursick JA , Heim KL , Hilleman DE , Reich JW Heparin-associated thrombocytopenia: A prospective comparison of bovine lung heparin, manufactured by a new process, and porcine intestinal heparin. Drug Intell Clin Pharm 20:374-378, 1986.

Loganathan D. , Wang HM , Mallis LM , Linhardt RJ Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources. Biochemistry 29:4362-4368, 1990.

Zucker MB , Nachmias VT Platelet activation. Arteriosclerosis 5:2-18, 1985.

Kroll MH , Schafer AI Biochemical mechanisms of platelet activation. Blood 74: 1181-1195, 1989.

Anderson GP , Anderson CL Signal transduction by the platelet Fc receptor . Blood 76: 1165-1172, 1990 .

Hackett T. , Kelton JG , Powers P. Drug-induced platelet destruction. Semin Thromb Hemost 8:116-137, 1982.

Pfueller SL , Bilston RA , Logan D. , Gibson JM , Firkin BG Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: Involvement of glycoproteins Ib, IIb, IIIa, and IX. Blood 72: 1155-1162, 1988.

Chong BH , Du X. , Berndt MC , Horn S. , Chesterman CN Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidinedependent antibodies . Blood 77:2190-2199, 1991 .

Smith ME , Reid DM , Jones CE , Jordon JV , Kautz CA , Shulman NR Binding of quinine-and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent . J Clin Invest 78:912-917, 1987.

Anderson GP Insights into heparin-induced thrombocytopenia . Br J Haematol 80: 504-508, 1992.

Kelton JG , Sheridan D. , Brain H. , Powers PJ , Turpie AG , Carter CJ Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 103:606-612, 1984.

Sheridan D. , Carter C. , Kelton JG A diagnostic test for heparin-induced thrombocytopenia . Blood 67:27-30, 1986.

Howe SE , Lynch DM An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin. J Lab Clin Med 105:554-559, 1985.

Gruel Y. , Rupin A. , Darnige L. , Moalic-Reverdiau P. , Poumier-Gaschard P. , Binet C. , Bardos P. , Leroy J. Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay. Thromb Res 62:377-387, 1991.

Salem HH , van der Weyden MB Heparin-induced thrombocytopenia. Variable platelet-rich plasma reactivity to heparin dependent platelet aggregating factor. Pathology 15: 297-299, 1983.

Hirsh J. , Levine MN Low molecular weight heparin. Blood 79:1-17, 1992.

Vitoux JF , Mathieu JF , Roncato M. , Fiessinger JN , Aiach M. Heparin-associated thrombocytopenia treatment with low molecular weight heparin . Thromb Haemost 55:37-39, 1986.

Robitaille D. , Leclerc JR , Laberge R. , Sahab P. , Atkinson S. , Cartier R. Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia. J Thorac Cardiovasc Surg 103:597-599, 1992.

Blockmans D. , Bounameaux H. , Vermylen J. , Verstraete M. Heparin-induced thrombocytopenia: Platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities. Thromb Haemost 55: 90-93, 1986.

Greinacher A. , Drost W Michels I, Leitl J, Gottsman M, Kohl HJ, Glaser M, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins. Ann Hematol 64:40-42, 1992.

Gouault-Heilmann M. , Huet Y. , Adnot S. , Contant G. , Bonnet F. , Intrator L. , Payen D. , Levent M. Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia . Haemostasis 17:134-140, 1987.

Tardy B. , Page Y. , Tardy-Poncet B. , Comtet C. , Zeni F. , Bertrand JC Low-molecular weight heparin induced thrombocytopenia. Therapie 45:453, 1990.

Nurmohamed MT , Fareed J. , Hoppensteadt D. , Walenga JM , ten Cate JW Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan . Semin Thromb Hemost 17(Suppl 2):205-213, 1991.

Munson PJ , Rodbard D. Number of receptor sites from Scatchard and Klotz graphs: A constructive critique . Science 220(4600):979-981, 1983.

Ortel TL , Gockerman JP , Califf RM , McCann RL , O'Conner CM , Metzler DM , Greenberg CS Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin-induced thrombocytopenia and thrombosis. Thromb Haemost 67: 292-296, 1992.

Rowlings PA , Evans S. , Mansberg R. , Murray B. , Rozenberg MC The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis. Aust N Z J Med 21:52-54, 1991.

Makhoul RG , Greenberg CS , McCann RL Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution. J Vasc Surg 4:522-528, 1986.

ten Cate H. , Lamping RJ , Henny CP , Prins A. , ten Cate JW Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity. Clin Chem 30:860-864, 1984.

Laster J. , Elfrink R. , Silver D. Reexposure to heparin of patients with heparin-associated antibodies . J Vasc Surg 9:677-682, 1989.

Makhoul RG , McCann RL , Austin EH , Greenberg CS , Lowe JE Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. Ann Thorac Surg 43:617-621, 1987.

Kappa JR , Cottrell ED , Berkowitz HD , Fisher CA , Sobel M. , Ellison N. , Addonizio VP Jr. Carotid endarterectomy in patients with heparin-induced platelet activation: Comparative efficacy of aspirin and Iloprost (ZK36374). J Vasc Surg 5:693-701, 1987.

Sobel M. , Adelman B. , Greenfield LJ Dextran 40 reduces heparin-mediated platelet aggregation. J Surg Res 40:382-387, 1986.

Clagett GP Antithrombotic drugs and vascular surgery. Perspect Vasc Surg 3(2):79-102, 1990.

Gryglewski RJ , Stock G. Prostacyclin and its Stable Analogue Iloprost. Berlin Heidelberg : Springer-Verlag, 1987 .

Kappa JR , Fisher CA , Berkowitz HD , Cottrell ED , Addonizio VP Jr. Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management. J Vasc Surg 5:101-109, 1987.

Demers C. , Ginsberg JS , Brill-Edwards P. , Panju A. , Warkentin TE , Anderson DR , Turner C. , Kelton JG Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia . Blood 78:2194-2197, 1991 .

Cole CW , Fournier LM , Bormanis J. Heparin-associated thrombocytopenia and thrombosis: Optimal therapy with ancrod . Can J Surg 33:207-210, 1990.

Zulys VJ , Teasdale SJ , Michel ER , Skala RA , Keating SE , Viger JR , Glynn MFX. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 71:870-877, 1989.

Matsuo T. , Chikahira Y. , Yamada T. , Nakao K. , Ueshima S. , Matsuo O. Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin-induced thrombocytopenia during hemodialysis. Thromb Res 52:165-171, 1988.

Matsuo T. , Yamada T. , Yamanashi T. , Ryo R. Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia. Thromb Res 58:663-666, 1990.

Manzano L. , Yebra M. , Vargas JA , Barbolla L. , Alvarez-Mon M. Plasmapheresis in heparin-induced thrombocytopenia and thrombosis. Stroke 21:1236, 1990.

Brady J. , Riccio JA , Yumen OH , Makary AZ , Greenwood SM Plasmapheresis: A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 96:394-397, 1991.

Dieck JA , Rizo-Patron C. , Unisa A. , Mathur V. , Ali Massumi G. A new manifestation and treatment alternative for heparin-induced thrombosis . Chest 98:1524-1526, 1990 .

Clifton GD , Smith MD Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis. Clin Pharm 5:597-601, 1986.

Cohen JI , Cooper MR , Greenber CS Streptokinase therapy of pulmonary embolic with heparin-associated thrombocytopenia . Arch Intern Med 145:1725-1726, 1985 .

Olinger GN , Hussey CV , Olive JA , Malik MI Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation . J Thorac Cardiovasc Surg 87:673-677, 1984.

Hyers TM , Hull RD , Weg JG Antithrombotic therapy for venous thromboembolic disease. Chest 95:37S-51S, 1989.

Suda Y. , Marques D. , Kermode JC , Kusumoto S. , Sobel M. Structural specificity of heparin binding to platelets [abstract] . Blood 78:218a, 1991.

Chong BH , Ismail F. , Cade J. , Gallus AS , Gordon S. , Chesterman CN Heparin-induced thrombocytopenia: Studies with a new low molecular weight heparinoid, Org 10172. Blood 73:1592-1596, 1989.

Jakubowski JA , Maraganore JM Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 75:399-406, 1990.

Märki WE , Wallis RB The anticoagulant and antithrombotic properties of hirudins. Thromb Haemost 64:344-348, 1990.

Hanson SR , Harker LA Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci USA 85:3184-3188, 1988 .

Sawyer RT Thrombolytics and anticoagulants from leeches. Bio Tech 9:513-518, 1991.

Heras M. , Chesebro JH , Webster MW , Mruk JS , Grill DE , Penny WJ , Bowie EJ , Badmion L. , Fuster V. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation 82:1476-1484, 1990.

Kelly AB , Marzec UM , Krupski W. , Bass A. , Cadroy Y. , Hanson SR , Harker LA Hirudin interruption of heparin-resistant arterial thrombus formation in baboons . Blood 77: 1006-1012, 1991 .

Jang I-K. , Gold HK , Ziskind AA , Leinbach RC , Fallon JT , Collen D. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition . Circulation 81:219-225, 1990.

Ruggeri ZM Inhibition of platelet-vessel wall interaction: Platelet receptors, monoclonal antibodies, and synthetic peptides. Circulation 81(Suppl 1):135-139, 1990.

Gold HK , Gimple LW , Yasuda T. , Leinbach RC , Werner W. , Holt R. , Jordan R. , Berger H. , Collen D. , Coller BS Pharmacodynamic study of F(ab )2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. J Clin Invest 86:651-659, 1990.